Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease

Pathology International

Volumn 62, Issue 6, 2012, Pages 407-411

  Mori, Fumiaki ^a   Tanji, Kunikazu ^a   Odagiri, Saori ^a,b   Hattori, Manabu ^c   Hoshikawa, Yasuko ^c   Kono, Chikao ^d   Yasui, Keizo ^d   Yokoi, Satoshi ^d   Hasegawa, Yasuhiro ^d   Kamitani, Tetsu ^f   Yoshida, Mari ^e   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Intranuclear inclusion body disease; NEDD8; NUB1; SUMO; Ubiquitin

Indexed keywords

NEDD8 PROTEIN; NUB1 PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BRAIN; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS INCLUSION BODY DISEASE; CLINICAL ARTICLE; DEGENERATIVE DISEASE; EOSINOPHIL; FRONTAL CORTEX; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL; PRIORITY JOURNAL; SPINAL CORD; SPINAL GANGLION;

AGED; BRAIN; BRAIN DISEASES; GANGLIA, SPINAL; HUMANS; INTRANUCLEAR INCLUSION BODIES; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SPINAL CORD; UBIQUITIN; UBIQUITINATION;

EID: 84861337603     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02812.x     Document Type: Article

References (24)

1. Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB. A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 1968; 10: 54-73.
2. Liu Y, Mimuro M, Yoshida M etal. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: Implications for clinical diagnosis. Acta Neuropathol 2008; 116: 615-23.
3. Soffer D. Neuronal intranuclear hyaline inclusion disease presenting as Friedreich's ataxia. Acta Neuropathol 1985; 65: 322-9.
4. Sone J, Hishikawa N, Koike H etal. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Neurology 2005; 65: 1538-43.
5. Takahashi-Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology 2003; 23: 351-9.
6. Munoz-Garcia D, Ludwin SK. Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 1986; 36: 785-90.
7. Weidenheim KM, Dickson DW. Intranuclear inclusion bodies in an elderly demented woman: A form of intranuclear inclusion body disease. Clin Neuropathol 1995; 14: 93-9.
8. Kimber TE, Blumbergs PC, Rice JP etal. Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci 1998; 160: 33-40.
9. Sone J, Tanaka F, Koike H etal. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 2011; 76: 1372-6.
10. Mori F, Miki Y, Tanji K etal. Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology 2011; 31: 188-93.
11. Pountney DL, Huang Y, Burns RJ etal. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol 2003; 184: 436-46.
12. Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H. SUMOylation substrates in neuronal intranuclear inclusion disease. Neuropathol Appl Neurobiol 2006; 32: 92-100.
13. McFadden K, Hamilton RL, Insalaco SJ etal. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. J Neuropathol Exp Neurol 2005; 64: 545-52.
14. Mori F, Tanji K, Kon T etal. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Neuropathol Appl Neurobiol. Article Accepted August 2011; doi: 10.1111/j.1365-2990.2011.01217.x.
15. Woulfe J, Gray DA, Mackenzie IR. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 2010; 20: 589-97.
16. Gitler AD, Shorter J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 2011; 5: 1-9.
17. Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating. Neuropathology 2011; 31: 401-4.
18. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 2001; 276: 46655-60.
19. Mori F, Nishie M, Piao YS etal. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 2005; 31: 53-61.
20. Tanji K, Tanaka T, Mori F etal. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol 2006; 169: 553-65.
21. Tanji K, Mori F, Kakita A etal. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol 2007; 114: 365-71.
22. Wakabayashi K, Engelender S, Tanaka Y etal. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol 2002; 103: 209-14.
23. Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett 2005; 381: 74-9.
24. Schimmel J, Larsen KM, Matic I etal. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics 2008; 7: 2107-22.